EichorEICHOR
Location: Newcastle Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Newcastle

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

International Leukemia Target Board
Phase N/A · Newcastle Hospital · Princess Maxima Center for Pediatric Oncology · NCT05270096Precision Medicine for Every Child With Cancer
Phase N/A · John Hunter Children's Hospital · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Royal Victoria Infirmary · Joseph Broderick, MD · NCT07227246Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodro
Phase 2 · Newcastle University · Michael J. Fox Foundation for Parkinson's Research · NCT07265596AusCADASIL: An Australian Cohort of CADASIL
Phase N/A · John Hunter Hospital · Perminder Sachdev · NCT06148051A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · Yonsei University · NCT06023862A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site GB44003 · Astellas Pharma Global Development, Inc. · NCT05970172A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · The Newcastle upon Tyne Hospitals NHS Foundation Trust · Vertex Pharmaceuticals Incorporated · NCT04786262Methods of T Cell Depletion Trial (MoTD)
Phase 2 · Freeman Hospital · University of Birmingham · NCT04888741A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · AbbVie · NCT06682988A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · The Newcastle upon Tyne Hospital FT · Alfasigma S.p.A. · NCT06865417Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06989359A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · Newcastle upon Tyne Hospitals · CellCentric Ltd. · NCT04068597The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · The Newcastle Hospitals NHS Foundation Trust · University of Oxford · NCT05169333Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Newcastle NIHR Commercial Research Delivery Centre · Amgen · NCT07037433PMCF (Post-Market Clinical Follow-up) Study on The Tether™ in UK (United Kingdom)
Phase N/A · Freeman Hospital · LDR Médical SAS · NCT05830825Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)
NA · Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust · King's College London · NCT07228468Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NA · John Hunter Hospital · University of Melbourne · NCT04434807A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Newcastle upon Tyne Hospitals NHS Foundation Trust |Freeman · Bayer · NCT07192952A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Regeneron Pharmaceuticals · NCT06091865A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Fore Biotherapeutics · NCT05503797A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced
Phase 1/Phase 2 · Northern Centre for Cancer Research · BioNTech SE · NCT07186842A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Royal Victoria Infirmary · Longboard Pharmaceuticals · NCT06660394A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Pfizer · NCT07144280Inari VISION Registry
Phase N/A · Royal Victoria Infirmary · Inari Medical · NCT06600542A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Freeman Hospital · Celgene · NCT05519085Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Freeman Hospital · Gilead Sciences · NCT06051617Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · NRG Oncology · NCT06532279
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.